Candriam SCA’s Chiasma, Inc. Common Stock CHMA Stock Holding History

Candriam SCA’s Portfolio CHMA Stock Details CHMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-23,500	Closed	-$111K	–	932
2021 Q2	$111K	Hold	23,500	–	–	﹤0.01%	848
2021 Q1	$98K	Hold	23,500	–	–	﹤0.01%	770
2020 Q4	$102K	Hold	23,500	–	–	﹤0.01%	784
2020 Q3	$101K	Hold	23,500	–	–	﹤0.01%	772
2020 Q2	$126K	Hold	23,500	–	–	﹤0.01%	766
2020 Q1	$114K	Hold	23,500	–	–	﹤0.01%	765
2019 Q4	$117K	Hold	23,500	–	–	﹤0.01%	784
2019 Q3	$116K	Hold	23,500	–	–	﹤0.01%	738
2019 Q2	$175K	Hold	23,500	–	–	﹤0.01%	800
2019 Q1	$122K	Hold	23,500	–	–	﹤0.01%	783
2018 Q4	$73K	Hold	23,500	–	–	﹤0.01%	778
2018 Q3	$85K	Hold	23,500	–	–	﹤0.01%	784
2018 Q2	$35K	Hold	23,500	–	–	﹤0.01%	766
2018 Q1	$35K	Buy	+23,500	New	+$37.3K	﹤0.01%	758

Candriam SCA's CHMA Position: Q3 2021 in Review

Candriam SCA sold out of Chiasma, Inc. Common Stock (CHMA) in Q3 2021, closing a stake of 23,500 shares — an estimated $111K sold.

Candriam SCA first reported a position in CHMA in Q1 2018 and held it in 14 quarters. The position peaked at $175K in Q2 2019. 0 funds tracked by Wall St. Rank hold CHMA as of Q3 2021.

Candriam SCA reported no remaining Chiasma, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Candriam SCA sold 23,500 Chiasma, Inc. Common Stock shares in Q3 2021, an estimated $111K.
Candriam SCA first reported a position in Chiasma, Inc. Common Stock in Q1 2018 and held it in 14 quarters.
Candriam SCA's Chiasma, Inc. Common Stock position peaked at $175K in Q2 2019.
0 funds tracked by Wall St. Rank held Chiasma, Inc. Common Stock as of Q3 2021.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.